NNEKA OSUDE: Open Payments
NPI 1295198661 · WAUCONDA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 31 payments from 11 companies in 2025. Trend: 2023 $479 · 2024 $224 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $187 |
| GENZYME CORPORATION | 1 | $114 |
| Teva Pharmaceuticals USA, Inc. | 2 | $55 |
| Exact Sciences Corporation | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Cranial Technologies, Inc | 2 | $29 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Verona Pharma, Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
Products named: VRAYLAR, QULIPTA, AUSTEDO XR, Doc Band, The Cologuard Plus Collection Kit, AIRSUPRA, UBRELVY, FARXIGA.
Industry payments across IL — which companies pay providers there.
